Cue Biopharma, Inc. (CUE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 28.92M |
| Enterprise Value | 5.99M |
| P/E Ratio | -4.86 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 2.15 |
| Price/Book Ratio | 5.97 |
| Enterprise/Revenue | 1.76 |
| Enterprise/EBITDA | -3.64 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.6 |
| Operating Margin | -0.6 |
| Return On Assets | -0.63 |
| Return On Equity | -0.98 |
| Revenue | 27.47M |
| Revenue/Share | 6.81 |
| Gross Profit | 27.47M |
| EBITDA | -22.27M |
| Net Income | -26.6M |
| Diluted EPS | -8.4 |
| Total Cash | 16.38M |
| Total Cash/Share | 3.41 |
| Total Debt | 3.44M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 3.57 |
| Book Value Per Share | 4.49 |
| 52-Week Change | 17.41 |
| 52-Week High | 45.5 |
| 52-Week Low | 4.98 |
| Moving Average 50 Days | 28.38 |
| Moving Average 200 Days | 18.14 |
| Average Volume | 179,870 |
| Shares Outstanding | 2.63M |
| % Held by Institutions | 14.83 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | April 24, 2026 |